Gerhard Zugmaier

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Blood cancer journal

Pediatric blood & cancer

Leukemia

Albert-Ludwigs-Universität Freiburg (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Albert-Ludwigs-Universität Freiburg

Germany

PHD :: Medical School

Publications

Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Franco Locatelli, Ana Markovic, Matthias Klinger, Ting Zeng, Gerhard Zugmaier
Transient and fully reversible changes in laboratory parameters and modifications of the cytokine profile during blinatumomab treatment in children with relapsed or refractory B-cell acute lymphoblastic leukemia. Pediatric blood & cancer (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Nicolas Boissel, Sabina Chiaretti, Cristina Papayannidis, Josep-María Ribera, Renato Bassan, Andrey N Sokolov, Naufil Alam, Alessandra Brescianini, Isabella Pezzani, Georg Kreuzbauer, Gerhard Zugmaier, Robin Foà, Alessandro Rambaldi
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study. Blood cancer journal 13 (1) (2023)
Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari, Joan D Morris, Bernd Gruhn, Thomas Klingebiel, Rosanna Parasole, Christin Linderkamp, Christian Flotho, Arnaud Petit, Concetta Micalizzi, Yi Zeng, Rajendra Desai, William N Kormany, Cornelia Eckert, Anja Möricke, Mary Sartor, Ondrej Hrusak, Christina Peters, Vaskar Saha, Luciana Vinti, Arend von Stackelberg
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL. Leukemia (2022)
Franco Locatelli, Cornelia Eckert, Ondrej Hrusak, Barbara Buldini, Mary Sartor, Gerhard Zugmaier, Yi Zeng, Deepali Pilankar, Joan Morris, Arend von Stackelberg
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia. Pediatric blood & cancer 69 (8) (2022)
Ester Mejstrikova, Matthias Klinger, Ana Markovic, Gerhard Zugmaier, Franco Locatelli
CD19 expression in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia pre- and post-treatment with blinatumomab. Pediatric blood & cancer 68 (12) (2021)
Franco Locatelli, Gerhard Zugmaier, Noemi Mergen, Peter Bader, Sima Jeha, Paul-Gerhardt Schlegel, Jean-Pierre Bourquin, Rupert Handgretinger, Benoit Brethon, Claudia Rossig, Christiane Chen-Santel
Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study. Blood cancer journal 11 (10) (2021)
Franco Locatelli, Gerhard Zugmaier, Noemi Mergen, Peter Bader, Sima Jeha, Paul-Gerhardt Schlegel, Jean-Pierre Bourquin, Rupert Handgretinger, Benoit Brethon, Claudia Rossig, Christiane Chen-Santel
Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study. Blood cancer journal 11 (2) (2021)
Franco Locatelli, Gerhard Zugmaier, Noemi Mergen, Peter Bader, Sima Jeha, Paul-Gerhardt Schlegel, Jean-Pierre Bourquin, Rupert Handgretinger, Benoit Brethon, Claudia Rossig, Christiane Chen-Santel
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study. Blood cancer journal 10 (7) (2020)

Gerhard Zugmaier.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gerhard Zugmaier